Business Context and Reporting Period
Company: TPG Specialty Lending, Inc. (Note: Input text identifies the registrant as TPG Specialty Lending, Inc., despite the user metadata referencing "Sixth Street Specialty Lending, Inc.")
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2014
Business Overview: A Delaware corporation regulated as a Business Development Company (BDC) and a Regulated Investment Company (RIC). The company focuses on lending to middle-market companies in the United States, primarily through direct originations of senior secured loans. The company completed its Initial Public Offering (IPO) in March 2014.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2014 | Nine Months Ended Sep 30, 2014 | Balance Sheet (Sep 30, 2014) |
|---|---|---|---|
| Total Investment Income | $38.4 million | $117.5 million | N/A |
| Net Investment Income | $23.1 million | $73.8 million | N/A |
| Net Increase in Net Assets from Operations | $18.6 million | $71.2 million | N/A |
| Earnings Per Share (Basic & Diluted) | $0.35 | $1.44 | N/A |
| Total Assets | N/A | N/A | $1,280.0 million |
| Total Investments (Fair Value) | N/A | N/A | $1,233.2 million |
| Total Debt | N/A | N/A | $382.2 million |
| Cash and Cash Equivalents | N/A | N/A | $9.2 million |
| Net Assets | N/A | N/A | $838.9 million |
| Net Asset Value Per Share | N/A | N/A | $15.66 |
| Asset Coverage Ratio | N/A | N/A | 319.5% |
Material Changes vs. Prior Period
- Portfolio Growth: Total investments at fair value increased to $1,233.2 million as of September 30, 2014, from $1,016.5 million at December 31, 2013. This growth was driven by new investment commitments of $248.6 million in the third quarter alone.
- Revenue Increase: Total investment income for the nine months ended September 30, 2014, rose to $117.5 million from $65.0 million in the prior year period. This increase is primarily attributed to the larger portfolio size and higher prepayment fees/accelerated amortization of fees due to repayments.
- Expense Increase: Net expenses for the nine months ended September 30, 2014, increased to $43.1 million from $24.4 million in the prior year. This reflects higher management fees (due to increased assets and cessation of fee waivers post-IPO) and higher incentive fees (rate increased to 17.5% post-IPO).
- Debt Structure: The company terminated its Subscription Credit Facility in March 2014. It issued $115 million in Convertible Senior Notes in June 2014 and expanded its Revolving Credit Facility commitments to $781.3 million.
- Unrealized Gains/Losses: The company reported a net change in unrealized losses of $0.9 million for the nine months ended September 30, 2014, compared to unrealized gains of $4.0 million in the prior year period, largely due to widening spreads and reversals of prior appreciation.
Guidance, Outlook, and Risks
- Outlook: Management believes trends in the middle-market lending environment, including limited capital availability and strong demand, will continue to create favorable investment opportunities. The company intends to continue generating cash from operations, borrowings, and future securities offerings.
- Dividends: The company declared quarterly dividends of $0.38 per share for the first three quarters of 2014. It maintains an "opt-out" dividend reinvestment plan.
- Stock Repurchase Plan: On November 3, 2014, the Board approved a plan to repurchase up to $50 million of common stock at prices below net asset value.
- Risks:
- Market Risk: Exposure to interest rate fluctuations (though 98.3% of debt investments are floating rate) and foreign currency exchange rates.
- Credit Risk: Economic downturns could impair portfolio companies' ability to operate, leading to investment losses.
- Liquidity Risk: Dependence on credit facilities and capital markets for funding; inability to access these markets could impair investment activities.
- Valuation Risk: Investments are valued in good faith by the Board; fair values may differ from amounts realized in a forced sale.
Investor Verification Checklist
- Fee Waiver Cessation: Verify the impact of the end of management fee waivers post-IPO on future net investment income margins.
- Convertible Notes: Review the terms of the $115 million Convertible Senior Notes, specifically the conversion price ($25.83) and the interest rate swap used to hedge the fixed rate.
- Portfolio Concentration: Confirm that no single investment exceeds 15% of the total portfolio and review the industry diversification (Healthcare and Pharmaceuticals is the largest sector at 16.2%).
- Asset Coverage: Monitor the asset coverage ratio (currently 319.5%) to ensure compliance with the 200% minimum requirement under the 1940 Act.
- Non-Accrual Status: Note that as of September 30, 2014, there were no investments on non-accrual status, but one investment was rated "4" (covenant violation) which was subsequently paid down.